| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NextCure, Inc. | Sr VP, General Counsel | Employee Stock Option (Right to Buy) | 8,270 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NXTC | NextCure, Inc. | 30 Jan 2026 | 1 | $0 | 4 | Sr VP, General Counsel | 03 Feb 2026, 16:07 |
| NXTC | NextCure, Inc. | 31 Jan 2025 | 1 | $0 | 4 | Sr VP, General Counsel | 03 Feb 2025, 18:23 |
| NXTC | NextCure, Inc. | 29 Mar 2024 | 1 | $0 | 4 | Sr VP, General Counsel | 02 Apr 2024, 16:45 |
| NXTC | NextCure, Inc. | 31 Jan 2024 | 1 | $0 | 4 | Sr VP, General Counsel | 01 Feb 2024, 16:45 |
| NXTC | NextCure, Inc. | 28 Feb 2023 | 1 | $0 | 4 | Sr VP, Legal Affairs | 01 Mar 2023, 17:01 |
| NXTC | NextCure, Inc. | 24 Feb 2023 | 0 | $0 | 3 | Sr VP, Legal Affairs | 28 Feb 2023, 19:33 |